Ultra Pouches key facts
as of Oct 2026- Manufacturer of nicotine-free oral pouches intended to support everyday mental focus and sustained energy.
- Ultra Pouches is valued at approximately $76.0M as of Oct 2026 (last reported valuation).
- It has raised $12.4M; the latest was Early Stage VC ($11.0M) in Jan 2026.
- Notable investors include Left Lane Capital, Good Friends, Sugar Capital, Barrel Ventures, Dak Prescott — 7 tracked in total.
- Status: Privately Held (backing).
Ultra Pouches's last reported valuation, Jan 2026. Nothing priced has surfaced since.
- ·Watch Ultra Pouches: the Monday email on marks, rounds and moves
Ultra Pouches funding rounds
No funding rounds for Ultra Pouches are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Ultra Pouches
7Ultra Pouches valuation
Ultra Pouches's last reported valuation was $76 million in Jan 2026. No priced round, secondary trade or fund mark has surfaced since.
Ultra Pouches investors
7 investors are on record for Ultra Pouches, including Left Lane Capital, Good Friends, Sugar Capital and Barrel Ventures.
About Ultra Pouches
Manufacturer of nicotine-free oral pouches intended to support everyday mental focus and sustained energy. The company offers oral pouches made with carefully selected natural ingredients, enabling working adults and students to stay attentive and mentally steady during periods of concentration.
- Sector
- Consumer Products and Services (B2C)
- HQ
- New York, NY, United States
- Founded
- 2025
- Employees
- 6
- Website
- takeultra.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.